Medical Device Translation: How to Avoid Regulatory Risks and Stay Audit-Ready

Ciklopea 7 hours ago 5 min

Medical device translation is one of the most sensitive fields for every language service provider.

medical device translation

Apart from the content translation and localization, the quality of which is non-negotiable, there are various international standards and domestic regulations that must be followed. 

Failing to follow these frameworks may pose serious risks to people’s health and lead to severe legal consequences. Staying on top of medical device translation rules and regulations reduces regulatory risks and keeps your organisation audit-ready and compliant. 

Medical Device Regulation Rules

The EU Medical Device Regulation (2017/745) prescribes that the manufacturers of medical devices must ensure proper labelling, instructions for use, and all other required information on the devices they produce. What’s more, all these details must be provided in the official languages of every EU member state where the device in question is available. 

It also refers to field safety notices, summary of safety and clinical performance (SSCP), implant cards, and software interfaces. To top it all, the differences on the national level of every member state are highlighted in the latest overview of language requirements, released in August 2025. 

In the context of the medical device translation services, it means more work, but also more compliance for translation companies. 

From IFU Translation Services to legislative frameworks, medical device translation procedures must meet the requirements under this regulation.

What’s more, global standards stipulate that information provided by medical device manufacturers must be written in a clear and understandable manner. For instance, reliable medical translation services must be carried out in line with ISO 13485 and other relevant quality, risk, and safety standards.

Here’s what every medical translation service provider can do to meet those medical device translation requirements: 

  • Analyse the potential language gaps based on the language requirements set by the Medical Device Coordination Group (MDCG). 
  • Include proper linguistic verification in your risk management files and design controls to ensure proper compliance. 
  • Rely on medical device translation procedures that are fully certified (think ISO 17100) and traceable.
  • Ensure high-quality medical device translation through expert human review, particularly for high-risk topics and content. 

 

Handling Ambiguities in Medical Translation Services

Translation is rarely a straightforward process. In highly regulated fields, where medical manufacturers and translation service providers belong, working in several languages at the same time requires special attention and expertise. 

For instance, both SSCPs and MDCG guidelines underline that implant cards must contain unambiguous content. One issue may be that domestic and national regulations don’t fully follow these instructions. 

Some countries may accept medical documentation in English, which still means medical professionals must be proficient in English. Others demand that medical content be translated into their national language. This is where grey areas appear more frequently. Unclear regulatory wording between different languages can lead to ambiguous information. 

Consequently, medical device manufacturers and providers of medical translation services might expose themselves to the risk of becoming non-compliant. 

This doesn’t refer only to strictly textual medical content, such as medical reports or analyses. The process of software interface localization or digital manual update demands that the same decision, word choice, or phrasing be handled in the same way. 

We suggest a few takeaways to avoid ambiguities and inconsistencies in your day-to-day medical device translation service: 

  • Note down the rationale based on which you make translation and operational decisions in grey areas; one day, an auditor might ask you about it.
  • Hire domestic medical experts to help you bring those decisions in line with the practical foundations.
  • Use back-translation. 
  • Create a framework that will ensure handling potential risks, in line with the MDCG documentation and the relevant local legal regulations. 

 

Quality Assurance and Regulatory Affairs Managers in the Field

The field of medical device translations requires continuous adaptation to compliance requirements and requests. It’s an ongoing process. That’s why translation and localization companies need to work with quality assurance (QA) and regulatory affairs (RA) experts. 

Those respective translation and legal pundits must keep proper documentation of judgment calls made at your translation company. When the time comes for an audit or compliance inspection, you need to possess the data about the translators’ qualifications and verification methods (usability checks, language tests). What’s more, such auditors may require to have an insight into your procedures for handling deviations and risks. 

Also, the relevant glossaries used at the translation company in question must be available for inspection. Language technology solutions and audit tracks significantly help document translation choices. 

In a nutshell, accountable persons at every medical device translation organisation need to keep documents about the inputs from stakeholders, risk assessment, and their own professional reasoning. 

Sorting Out Linguistic Deviations Naturally

Linguistic deviations can happen in any medical device translation. When we say linguistic deviations, we mean contextual mismatches, wording issues, and terminology discrepancies. It’s important to handle them naturally to avoid overloading quality systems. Following practical principles for deviation management, based on ISO 13485, should make this process simpler and easier. 

Those who are still asking themselves, “What is ISO 13485?” should know that it’s an international quality standard that every manufacturer of medical devices needs to meet. As a result, any business entity collaborating with such manufacturers or carrying out operations related to medical devices needs to follow ISO 13485. Logically, this includes medical translation, as well as life sciences language services

Every translation provider – and any other relevant organisation handling medical or pharmaceutical procedures and products – that becomes the ISO13485 certified translation partner increases its chances of landing global deals with renowned brands from the medical industry.
When handling linguistic issues that may incur risks if applied in practice, make sure to properly prioritise this procedure, i.e., to apply the corrective action and preventive action (CAPA) plan adequately. 

The first deviations to sort out are the ones that affect data security and overall safety. Then follows handling smaller deviations, such as additionally training the in-house translators or adapting the glossaries. 

What’s Next for Medical Device Translation?

The growth of AI-powered translation solutions and the further development of medicine as a science are among the most obvious challenges for medical device translation providers. We need to bear in mind that the touch of a human translator and editor will be more important than ever before. 

Machines can translate, but only seasoned language translators and medical experts can check whether the translation in question is useful and safe. 

Reach out to Ciklopea if you need life sciences and medical device translation. Check out why we’ve been one of the most reliable translation and localization providers in Europe for more than 20 years. 

Related Articles

From Guesswork to Growth: How Data-Driven Language Strategy Transforms Global Business Success

11 months ago

In today’s interconnected economy, the difference between companies that thrive globally and those that struggle often comes down to one critical factor: how they approach language strategy and localization planning. While many organizations still rely on intuition or outdated market assumptions, forward-thinking companies are embracing a fundamentally different approach—one powered by data, precision, and strategic insight. 

Continue reading